Revenue segments as reported by the company.

Skin Care

Makeup

Fragrance

Hair Care

Other

Returns/charges associated with restructuring and other activities and adjustments

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Restructuring and other charges

Goodwill impairment

Impairment of other intangible assets

Talcum litigation settlement agreements

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Estee Lauder

Aveda is a company founded by Horst Rechelbacher, now owned by Estée Lauder Companies, headquartered in the Minneapolis suburb of Blaine, Minnesota. Aveda manufactures skin and body care, cosmetics, perfume, hair color, hair care products, and trains students in cosmetology, massage and esthiology at the Aveda Institutes in Minneapolis, New York City, Des Moines, Washington, DC, Maryland, Vancouver, Calgary, Orlando, Denver, Toronto and many other cities.

Aveda

Clinique is an American manufacturer of skincare, cosmetics, toiletries and fragrances, usually sold in high end department stores. It is a subsidiary of the Estée Lauder Companies.

Clinique

The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under the following brand names: Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. Its channels consist of department stores, multi-brand retailers, upscale perfumeries and pharmacies, and prestige salons and spas. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Estée Lauder reports Q1 earnings, addresses Asia travel retail challenges

Estée Lauder Companies faced challenges in Asia travel retail but demonstrated strength in global retail performance, particularly in key markets and skincare products. The company is focused on addressing inventory and supply chain volatility while aiming for double-digit growth in sales. Despite ongoing risks, the long-term importance of travel retail and recovery markets presents opportunities for the company.

Estee Lauder faces Q2 challenges but eyes growth in fiscal '24

Estee Lauder's Q2 2023 showed mixed results with declines in organic sales and adjusted EPS, but with bright spots in fragrance and certain markets.
Challenges in skin care and geographic variations were noted, alongside opportunities for margin expansion and growth in fiscal '24.
The company remains focused on strategic investments, including the acquisition of Tom Ford, to drive sustainable growth and navigate market dynamics.
Overall, Estee Lauder is adapting to evolving conditions, aiming for recovery in key segments and regions while preparing for future opportunities.

Estee Lauder faces Q3 challenges in Asia travel retail

Estee Lauder's Q3 2023 earnings call highlighted challenges in Asia travel retail impacting overall performance, leading to a decline in organic sales and adjusted diluted EPS. Despite these challenges, the company remains focused on rebuilding margins, investing in key markets, and driving innovation. Opportunities for growth are seen in the recovery of airport traffic and strategic initiatives in travel retail.

Estee Lauder aims for growth rebound in fiscal '24 amidst challenges

Estee Lauder's Q4 2023 saw organic sales growth driven by EMEA and Asia Pacific, but full-year sales declined due to Asia travel retail challenges. Fiscal '24 targets margin expansion and organic sales growth, with a focus on brand strength and market opportunities.
The company faces challenges in Asia travel retail and external market volatility, but remains optimistic about growth prospects. Strategic imperatives for fiscal '24 include driving growth in key markets, launching new products, and enhancing profitability.
Opportunities lie in leveraging brand strength, expanding in emerging markets like India, and improving travel retail performance. Efforts to enhance supply chain agility and balance value creation in retail collaborations are key focus areas for growth.

Estee Lauder Q1 2024: Mixed Results, Strategic Imperatives for Growth

Estee Lauder's Q1 2024 showed mixed results with challenges in travel retail but strengths in key markets like EMEA and Asia Pacific.
The company is focused on strategic imperatives for growth, cost efficiency, and sustainability, aiming to rebuild profitability.
Despite challenges, Estee Lauder remains confident in its fundamentals and brand portfolio for future growth opportunities.

Estee Lauder reports Q2 sales decline but exceeds EPS expectations

Estee Lauder is navigating a challenging sales environment but remains focused on profitability rebuild and long-term growth. The company is implementing a Profit Recovery Plan, expanding strategic initiatives globally, and aiming for a return to organic sales growth in key markets.

Estee Lauder reports strong Q3 earnings and outlines profit recovery plan

Estee Lauder's Q3 performance showcased strong sales growth in key regions, with a focus on operational efficiency and margin improvement.
The company's profit recovery plan aims to drive significant incremental operating profit through strategic initiatives and expense management.
Challenges in Mainland China and disruptions in retail sell-through were noted, but Estee Lauder remains optimistic about growth opportunities and market trends.
Analysts' inquiries focused on margin trends, spending shifts, and the pace of reinvestment, highlighting investor interest in Estee Lauder's financial strategies and market performance.

Estee Lauder addresses challenges, focuses on growth strategies for 2025

Estee Lauder's fiscal year 2024 was challenging, but the company is taking strategic actions to address issues and drive growth in fiscal year 2025. Despite expected sales challenges, Estee Lauder is focused on key growth areas and operational improvements to navigate market conditions.

Estee Lauder faces sales decline in Q1 2025 amidst market challenges

Estee Lauder navigated a challenging Q1 2025 with a sales decline and withdrawn outlook. Despite headwinds, the company showed strengths in key product categories and market share gains. Addressing cost pressures and strategic focus are crucial for future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Estée Lauder Companies, Inc. engages in the manufacture of skin care, makeup, fragrance and hair care products. It sells products under Estée Lauder, Clinique, Origins, MAC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. Its channels consist of department stores, multi-brand retailers, upscale perfumeries and pharmacies, and prestige salons and spas. The company was founded by Estee Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.

Estée Lauder owns a large suite of upscale cosmetics brands. Sales and income are declining year over year, and management lowered full-year guidance.

Why Estée Lauder Stock Dropped 21% in the First Half of 2023

Estee Lauder's stock is down by 22% year to date. Estee Lauder's strong brand presence helped them dominate the beauty market. The company's plans to close underperforming stores will minimize costs and boost e-commerce sales.

Estee Lauder Stock: Well-Positioned For Long-Term Growth

Findings indicate sirtuins, or longevity proteins, are instrumental in regulating the mechanobiology of the skin and promoting youthful skin properties and function First-of-its-kind study confirms impact of regular use of moisturizer to mitigate skin aging Topical treatment proven as viable alternative to dermatological procedure NEW YORK , July 6, 2023 /PRNewswire/ -- The Estée Lauder Companies Inc. (ELC) (NYSE: EL) today announced that the company and several of its brands presented a range of novel preclinical and clinical findings at the 25th World Congress of Dermatology, held this week in Singapore. The poster and satellite symposium presentations reflect a strong portfolio of prestige beauty and skin care brands effectively translating biological learnings and progressive research efforts into meaningful innovation, including better methods to care for and protect skin.

The Estée Lauder Companies Shares New Preclinical and Clinical Findings at World Congress of Dermatology Spanning Emerging Research Areas that Support Skin Health and Longevity

Agilent Technologies

Autodesk

Amgen

Bank of America

Biogen

Bank of New York Mellon

Blackrock Inc

Comcast

CME Group

Compass Minerals

Campbell Soup

Copart

Cheniere Energy Partners

Corteva Inc

Disney

Domino's Pizza

Ecolab

Equifax

Emerson Electric

Etsy

General Dynamics

Gilead Sciences

Alphabet

Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analysis.

U.S. Wide-Moat Stocks On Sale - The July 2023 Heat Map

Estee Lauder (EL) is poised to benefit from its online business, investments in new technology and digital experiences, as well as its strength in emerging markets. However, high operating expenses remain a concern.

Estee Lauder (EL) Gains From Emerging Market Presence Amid Risks

Cie Financiere Richemont SA

MarineMax

Mercedes-Benz Group AG

Kering SA

Here's how to cash in on luxury stocks whose businesses cater to big spenders.

Why Luxury Stocks are Worth Investing In

Bath and Body Works

There is no question that large-cap stocks are the winners in 2023 thus far.  The S&P 500 is up more than 14% year-to-date.

These 3 Large-Cap Stocks Are on Sale: Buy Them Now

We discuss the recent weak performance of Estée Lauder, attributing it to the slow recovery of Asia's travel retail business. However, we believe the recovery is on its way. The strength of the cosmetics industry is highlighted, which has seen steady growth over the past 20 years and is considered recession-proof. Estée Lauder and L'Oréal are identified as the two leading players in the market, consistently gaining market shares from smaller companies.

Estee Lauder: Asia Travel Retail Recovery Is On The Way

The Beauty Health Company

Ulta Beauty

While the concept of best beauty stocks might not arouse any particularly strong emotion, the basis for the current bullish thesis might. Yes, I'm talking about the dreaded return to the office.

The 3 Best Beauty Stocks to Buy for the Back-to-Office Boom

This personal care stock is dramatically underperforming the market.

This Stock Is Down 21% in 2023 – Time to Buy?

Comfort Systems USA

Hanesbrands

Individual investors have an edge in investing if they buy stock in products they like and understand. It's also important to pay attention to when the situation changes, because that could change your investing thesis.

Looking for Stocks to Buy? Consider Peter Lynch's Advice

Eli Lilly

Although these companies are from different sectors, we compare them because they have a similar operating income of $8-10 billion.

Cross-Sector Comparison: Is Estee Lauder A Better Pick Over LLY Stock?

Another analyst joins the ranks of bullish pundits. Berenberg has upped its recommendation from neutral to buy.

Why Estee Lauder Stock Was Smelling Sweet This Week

NIKE

QUALCOMM

A lot of times, people view things as a binary. A potential investment is a growth company or a value stock.

Discover Hidden Growth Potential of These 3 Blue-Chip Stocks

ELC to Present Novel Scientific Data Spanning Emerging Research Areas and Clinical Progress to Promote Skin Health and Anti-aging at World Congress of Dermatology NEW YORK , June 14, 2023 /PRNewswire/ -- The Estée Lauder Companies Inc. (ELC) (NYSE: EL) today announced that the company and its brands will present at the 25th World Congress of Dermatology (WCD) in Singapore from July 3-8, 2023. ELC researchers across 3 brands and ELC Research & Development (R&D) will share novel clinical and preclinical results that demonstrate scientific innovation and leadership across emerging areas of skin health and anti-aging in the form of 5 poster presentations and a satellite symposium during this global event, which takes place every 4 years.

The Estée Lauder Companies to Present Novel Scientific Data at World Congress of Dermatology

Estée Lauder is facing a slowdown in its travel retail business. Profit margins at the cosmetics and fragrances powerhouse are shrinking.

Down Over 50% and Near a 4-Year Low, Is It Finally Time to Buy Estée Lauder Stock?

Shares of Estee Lauder continue to fall as the company continues to cut the guidance. The operational weakness is prolonged and severe, making me very cautious. Current performance does not provide fundamental support, and with shares still looking expensive based on 2022 peak earnings, I am very cautious.

Estee Lauder: Still Not Pretty

NVIDIA

Zscaler

Semiconductor stocks are surging as investors anticipate a cyclical recovery and growth fueled by AI. Retail and consumer staples stocks struggled through troublesome economic data and weak quarterly earnings.

4 Stocks That Moved the Market in May

IMAX

Clear Secure

Dave & Buster's

PayPal

Sibanye Stillwater

With the labor market printing a much hotter-than-anticipated figure for the month of May, speculators may be emboldened to consider high-risk stocks to buy. Ever since the Covid-19 disaster (and even earlier), more than a few voices have sounded the alarm about a possible recession.

7 High-Risk Stocks That Could Skyrocket in the Next 12 Months

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies (NYSE: EL) (“ELC”) is excited to announce the second edition of BEAUTY&YOU. Created by ELC's New Incubation Ventures (“NIV”) and launched in partnership with India's preferred beauty and lifestyle retailer, NYKAA, BEAUTY&YOU aims to continue its mission to discover, spotlight and propel the next generation of Indian beauty brands. The program supports India-focused companies, entrepreneurs, innovators, and creators through a competit.

Introducing BEAUTY&YOU 2023: Supporting The Next Generation Of Indian Beauty Entrepreneurs and Creators

Analog Devices

Aspen Technology Inc

Cisco Systems

U.S. Wide-Moat Stocks On Sale - The June 2023 Heat Map

News for Estee Lauder Stock (EL)